Latest Updates on CAR-T in Multiple Myeloma

 

Insights from 2023 ASCO® Annual Meeting
D

ASCO® 2023 Insights: "Safety and Efficacy of Standard of Care Cilta-Cel for R/R MM"

By Insights from 2023 ASCO® Annual Meeting FEATURING Doris Hansen
By Insights from 2023 ASCO® Annual Meeting FEATURING Doris Hansen
104 views
June 15, 2023
0 Comments
Login to view comments. Click here to Login
Latest Updates on CAR-T in Multiple Myeloma
04:32
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 1b/2 CARTITUDE-1 Study Final Result…

Feat. Y. Lin
02:48
ecancer

2023 EHA® Insights: "Final Results From the CARTITUDE-1 Study o…

Feat. N. Munshi
11:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "First Phase 3 Results From CARTITUDE-4 - …

Feat. B. Dhakal
06:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Safety and Efficacy of Standard of Care C…

Feat. D. Hansen
04:17
ecancer

ASCO® 2023 Insights: "CARTITUDE-4 Study Summary - Cilta-Cel Vs.…

Feat. B. Dhakal
07:11
GRACE

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

Feat. A. Goodman, A. Jeong, S. Rajeeve
10:32
Penn Medicine Abramson Cancer Center

Penn Medicine Updates From Recent Meetings in Hematologic Malignanci…

Feat. A. Garfall
16:45
Francesca Cottini

Patient Selection for CAR-T Therapy in R/R MM: Disease and Patient F…

16:05
Maximilian Merz

Efficacy of CAR-T Treatment in R/R MM: Available and Emerging Agents

24:19
Vanderbilt University Medical Center (VUMC)

The Rapidly Growing Landscape of BCMA-Targeted Therapies

Feat. E. Biltibo
04:47
Patrick Johnson

Longitudinal QoL in Patients With R/R Hematologic Malignancies That …

07:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…

Feat. L. Shune
23:40
Dana-Farber Cancer Institute

Update on CAR T-Cells in Multiple Myeloma

Feat. A. Sperling
29:56
UChicago Medicine

2023 Practice-Changing and Promising New Treatments in Myeloma

Feat. B. Derman
12:41
UChicago Medicine

Clinical Trial Considerations in MM: BCMA-Directed Therapy

Feat. J. Cooperrider
17:42
UChicago Medicine

CAR-T and BiTE Therapy in Myeloma

Feat. R. Malloy
09:49
University of Colorado Division of Hematology

2023 Denver ASH Review: Updates in Multiple Myeloma (Updates in CAR …

Feat. D. Sherbenou
41:31
University of Colorado Division of Hematology

2023 Denver ASH Review: Updates in CAR-T Therapies

Feat. T. Fry
42:37
University of Colorado Department of Medicine

Multiple Myeloma in 2023: An Oncological Success Story

Feat. P. Forsberg
08:13
Shaji Kumar

CAR-T in MM: Benefits of a Treatment-Free Interval

09:14
i3 Health

Leveraging BCMA-Directed Therapies to Improve Patient Outcomes in R/…

Feat. R. Banerjee
26:05
Indy Hematology Review

Understanding and Managing Immune Effector Cell Toxicities in Hemato…

Feat. D. Reeves
24:39
Icahn School of Medicine at Mount Sinai

Adverse Effects of CAR-T: Myeloma Edition

Feat. S. Rajeeve
13:36
Vanderbilt University Medical Center (VUMC)

Venous Thromboembolism Prophylaxis in Newly Diagnosed MM

Feat. M. Baljevic
20:19
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …

Feat. A. Paulus